Clinuvel Pharmaceuticals Limited (FRA:UR9A)
6.60
+0.05 (0.76%)
At close: Dec 4, 2025
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of €352.86 million as of December 5, 2025. Its market cap has decreased by -11.66% in one year.
Market Cap
352.86M
Enterprise Value
225.40M
Revenue
53.04M
Ranking
n/a
PE Ratio
17.47
Stock Price
€6.60
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 3.03M to 352.86M, an increase of 11,549.00%. That is a compound annual growth rate of 21.13%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |